Full access

Letter to the Editor

Published Online: 1 November 1999

Length of Therapy for Depression Treatment

JOHN TRAVERS, M.D., M.P.H.Authors Info & Affiliations

Publication: American Journal of Psychiatry

https://doi.org/10.1176/ajp.156.11.1839-a

To the Editor: I read with interest the recent article by Frederick W. Reimherr, M.D., and colleagues (1) and congratulate the authors for studying the clinically important topic of optimal length of therapy for the treatment of depression.

The value of this contribution is lessened, however, by their failure to address the risks associated with continuation therapy. Other reports of antidepressant continuation therapy (2–5) have included an assessment of adverse experiences, often with comparisons of adverse experiences occurring during acute therapy and long-term treatment. Data regarding adverse experiences are as helpful to the clinician as are descriptions of efficacy parameters.

As the authors mention in their introductory remarks, patients may be reluctant to participate in long-term medication therapy out of concern for side effects. I question how the authors can adequately determine the optimal length of therapy without an assessment of treatment risks and the hope that future studies balance education about the risks involved with information regarding benefits.

References

Reimherr FW, Amsterdam JD, Quitkin FM, Rosenbaum JF, Fava M, Zajecka J, Beasley CM Jr, Michelson D, Roback P, Sundell K: Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry 1998; 155:1247–1253

Google Scholar

Doogan DP, Caillard V: Sertraline in the prevention of depression. Br J Psychiatry 1992; 160:217–222

Crossref

PubMed

Google Scholar

Montgomery SA, Dunbar G: Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 1993; 8:189–195

Google Scholar

Ohrberg S, Christiansen PE, Severin B, Calberg H, Nilakantan B, Borup A, Sogaard J, Larsen SB, Loldrup D, Bahr B, Siebuhr N, Gregersen B, Jacobsen F, Liljeström M, Manniche PM, Bech P: Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice. Acta Psychiatr Scand 1992; 86:437–444

Google Scholar

Van Moffaert M, Bartholome F, Cosyns P, De Nayer AR, Mertens C: A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression. Human Psychopharmacology 1995; 10:393–405

Crossref

Google Scholar

Information & Authors

Information

Published In

American Journal of Psychiatry

Volume 156 • Number 11 • November 1999

Pages: 1839-a - 1839

History

Published online: 1 November 1999

Published in print: November 1999

Authors

Details

JOHN TRAVERS, M.D., M.P.H.

Collegeville, Pa.

View all articles by this author

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format	RIS (ProCite, Reference Manager) EndNote BibTex Medlars RefWorks
Direct importt
Citation style
Style

Copy to clipboard
Tips for downloading citations

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR^® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Length of Therapy for Depression Treatment

References